Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango?

ABSTRACT: In this review article we discuss the role of the memory T cells in multiple myeloma (MM) and how they may influence immune responses in patients that received immunomodulating drugs and check point therapy.

SUBMITTER: Sponaas AM 

PROVIDER: S-EPMC7928324 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature